Form 4 for NRXS Neuraxis, INC
Accepted 2026-02-26 00:00:00 ET · period of report 2026-01-22 · accession 0001493152-26-008234 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | 2026-01-22 | NRXS | Keyser Jane Elizabeth | Dir | A - Grant | $4.63 | +21.6K | 46.3K | +87% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-22 | A | A | 21,598 | $4.63 | 46,335 | D | — | — | (F1) These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer. |